Skip to main content

Animations

MJFF Publications

2701 - 2710 of 9156 Results
Title
Year
  • Year
  • 2015
  • 2015
  • 2021
  • 2021
  • 2021
  • 2018
  • 2026
  • 2025
  • 2014
  • 2016
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0055-2
    Citation Count: 45
  • Summary Details
    OPEN
    Title: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26102
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participants
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100094
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524
    Citation Count: 1
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Lack of Cerebrospinal Fluid α‐Synuclein Seeding in VPS35 D620N ‐ and LRRK2 Y1699C ‐Linked Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70291
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Self-management for people with epilepsy and a history of negative health events (SMART): A randomized controlled effectiveness trial
    Journal Name: Epilepsy & Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.yebeh.2025.110495
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004
    Citation Count: 51
  • Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
    2016
    Summary Details
    RESTRICTED
    Title: Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26882
    Citation Count: 33
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.